González-Martín Ana María, Aguilera-García Iván, Castellote-Caballero Yolanda, Rivas-Campo Yulieth, Bernal-Suárez Antonio, Aibar-Almazán Agustín
Department of Education and Psychology, Faculty of Social Sciences, University of Atlántico Medio, 35017 Las Palmas de Gran Canaria, Spain.
Department of Psychology, Higher Education Center for Teaching and Educational Research, Plaza de San Martín 4, 28013 Madrid, Spain.
Cancers (Basel). 2023 Aug 16;15(16):4123. doi: 10.3390/cancers15164123.
(1) Objective: To review the existing evidence on pain education in patients with pain derived from an oncological process. (2) Methods: A systematic review was conducted using the databases Pubmed, Web of Science, PEDro, and Scopus. The selected studies had to incorporate instruction about the neurophysiology of pain into their educational program. The target population was cancer patients who had suffered pain for at least one month. The methodological quality of the articles collected was assessed using the PEDro scale. (3) Results: Some 698 studies were initially identified, of which 12 were included in this review. Four different models of pain education programs were found in the studies' interventions. Pain intensity, pain experience, quality of life, pain tolerance, and catastrophism were the variables that appeared most frequently. (4) Conclusions: This review demonstrates that pain education in patients with cancer pain may produce effects such as decreased pain intensity and catastrophism. Knowledge about pain also seems to increase. However, no benefit was reported for patients' overall quality of life. Therefore, more research is needed to clarify the effects of these interventions on the oncology population.
(1) 目的：回顾有关肿瘤源性疼痛患者疼痛教育的现有证据。(2) 方法：使用PubMed、科学网、PEDro和Scopus数据库进行系统综述。所选研究必须在其教育项目中纳入有关疼痛神经生理学的指导。目标人群为经历疼痛至少1个月的癌症患者。使用PEDro量表评估所收集文章的方法学质量。(3) 结果：最初识别出约698项研究，其中12项纳入本综述。在研究干预措施中发现了四种不同的疼痛教育项目模式。疼痛强度、疼痛体验、生活质量、疼痛耐受性和灾难化思维是出现最频繁的变量。(4) 结论：本综述表明，癌症疼痛患者的疼痛教育可能产生诸如降低疼痛强度和灾难化思维等效果。对疼痛的认知似乎也有所增加。然而，未报告对患者总体生活质量有益处。因此，需要更多研究来阐明这些干预措施对肿瘤患者群体的影响。
